Smart Grid

TMCNet:  Market Maker Surveillance Report. TZOO, OSTK, THRX, ESI, CRME, UGAZ, Winning Stocks With Lowest Price Friction For Thursday, April 18th 2013

[April 19, 2013]

Market Maker Surveillance Report. TZOO, OSTK, THRX, ESI, CRME, UGAZ, Winning Stocks With Lowest Price Friction For Thursday, April 18th 2013

Apr 19, 2013 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 4037 companies with "abnormal" market making, 1930 companies with positive Friction Factors and 3188 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Thursday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Travelzoo Inc (NASDAQ:TZOO), Overstock.com Inc (NASDAQ:OSTK), THERAVANCE, INC. (NASDAQ:THRX), ITT EDUCATIONAL SERVICES INC (NYSE:ESI), CARDIOME PHARMA CORP (NASDAQ:CRME), (NYSE:UGAZ). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Story continues below ↓

Market Maker Friction Factor is shown in the chart below: Symbol Change Percent Buy Volume Buy %% Sell Volume Sell %% Net Volume Friction TZOO $2.600 11.97% 318,034 49.51% 313,479 48.80% 4,555 18 OSTK $4.340 37.87% 840,115 52.41% 751,014 46.85% 89,101 205 THRX $4.550 16.24% 4,706,627 54.39% 3,716,437 42.95% 990,190 2,176 ESI $1.490 11.09% 287,963 33.95% 242,510 28.59% 45,453 305 CRME $0.260 13.69% 94,492 59.15% 62,769 39.29% 31,723 1,220 UGAZ $5.300 15.08% 131,158 42.97% 91,890 30.11% 39,268 74 Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows TZOO with a dollar gain Thursday of $2.60000 and a Friction Factor of 18 shares. That means that it only took 18 more shares of buying than selling to move TZOO higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

Travelzoo Inc (NASDAQ:TZOO) - Travelzoo Inc., an Internet media company, together with its subsidiaries, publishes travel and entertainment deals from travel and entertainment companies, and local businesses in North America, Europe, and the Asia Pacific. The company s publications and products include the Travelzoo Websites, such as travelzoo.com, travelzoo.ca, travelzoo.co.uk, travelzoo.de, travelzoo.es, and travelzoo.fr; the Travelzoo iPhone and Android applications; the Travelzoo Top 20 e-mail newsletter; and the Newsflash e-mail alert service. It also operates SuperSearch, a pay-per-click travel search tool; and the Travelzoo Network, a network of third-party Websites that list deals published by the company. In addition, the company has Fly.com, a travel search engine that allows users to find the best prices on flights from various airlines and online travel agencies; and operates Local Deals and Getaway services, which allow its subscribers to purchase vouchers for deals from local businesses, such as spas, hotels, and restaurants through the Travelzoo Website and mobile applications. It serves airlines, hotels, cruise lines, vacations packagers, tour operators, destinations, car rental companies, travel agents, theater and performing arts groups, restaurants, spas, and activity companies. Travelzoo Inc. was founded in 1998 and is headquartered in New York, New York..

Overstock.com Inc (NASDAQ:OSTK) - Overstock.com, Inc., together with its subsidiaries, operates as an online retailer offering discount brand name, non-brand name, and closeout merchandise in the United States and internationally. The company s merchandise include bed-and-bath goods, furniture, home decor, kitchenware, watches and jewelry, shoes, electronics and computers, sporting goods, apparel, designer accessories, home and garden products, media, music, luggage, health and beauty products, baby products, crafts and sewing products, office products, gifts and flowers, toys and hobbies, and pet products. It also operates online car listing service that allows sellers to list vehicles for sale and allows buyers to review vehicle descriptions; travel shopping site, which offers discount travel packages, flights, rental cars, and other travel-related products and services; and insurance shopping service for auto and home insurance, as well as provides books, magazines, CDs, DVDs, and video games. The company markets its products and services through its operating Internet websites, which include overstock.com, o.co, and o.biz. The company was formerly known as D2-Discounts Direct and changed its name to Overstock.com, Inc. in October 1999. Overstock.com, Inc. was founded in 1997 and is based in Salt Lake City, Utah..

THERAVANCE, INC. (NASDAQ:THRX) - Theravance, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule medicines primarily for therapeutic areas of respiratory diseases, bacterial infections, and central nervous system (CNS)/pain. The company offers VIBATIV, a bactericidal injectable antibiotic for the treatment of Gram-positive infections. Its principal development programs with GlaxoSmithKline plc include the RELOVAIR that has completed Phase 3 clinical studies for the treatment of patients with chronic obstructive pulmonary disease (COPD) or asthma; the LAMA/LABA combination, a Phase 3 program for patients with COPD; and the Bifunctional Muscarinic Antagonist-Beta2 Agonist (MABA) program that has completed Phase 2b study for the treatment of COPD. The company s principal development programs also comprise and the Peripheral Mu-Opioid Receptor Antagonist (P MA) program for the TD-1211 mu-opioid receptor designed to alleviate gastrointestinal side effects of opioid therapy without affecting analgesia. In addition, it develops TD-4208 that has completed Phase 2a single-dose COPD study; TD-1792, an antibiotic under clinical-stage for the treatment of serious infections caused by Gram-positive bacteria; MARIN program with compound TD-9855 under Phase 2 study for the treatment of attention-deficit/hyperactivity disorder; TD-5108, which has completed Phase 1 study for the treatment of Alzheimer s disease, and completed Phase 2 proof-of-concept study for the treatment of chronic idiopathic constipation(CIC); and TD-8954 that has completed single- and multiple-ascending dose Phase 1 studies for treatment of CIC. The company was formerly known as Advanced Medicine, Inc. and changed its name to Theravance, Inc. in April 2002. Theravance, Inc. was founded in 1996 and is headquartered in South San Francisco, California..

ITT EDUCATIONAL SERVICES INC (NYSE:ESI) - ITT Educational Services, Inc. provides postsecondary degree programs in the United States. It offers master, bachelor, associate, and career-oriented education programs in various fields, such as information technology, electronics technology, drafting and design, business, criminal justice, and nursing and health sciences. The company s information technology programs include communications, network administration, technical support, network technology, and systems technology; and electronics technology programs comprise communications, computer technology, electronics product design and fabrication, industrial electronics, instrumentation, and telecommunications. Its drafting and design programs comprise architectural and construction drafting, civil drafting, computer aided drafting, electrical and electronics drafting, interior design, landscape architecture, mechanical drafting, and multimedia communications; business programs include accounting, business administration, financial services, manufacturing, marketing and advertising, and sales; and criminal justice programs consist of corrections, cyber security, investigations, and security and policing. The company s health sciences programs consist of health information technology and nursing. As of December 31, 2011, it provided master, bachelor, and associate degree programs to approximately 73,000 students in 144 locations, including 141 campuses and 3 learning sites in 39 states, as well as online programs to students who are located in 48 states. The company was founded in 1946 and is headquartered in Carmel, Indiana..

CARDIOME PHARMA CORP (NASDAQ:CRME) - Cardiome Pharma Corp., a research-based biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs to treat or prevent cardiovascular and other diseases. The company offers BRINAVESS, a product approved for marketing in the European Union, Iceland, and Norway for the conversion of recent onset atrial fibrillation to sinus rhythm in adults. It also has clinical programs, which focuses on the treatment of atrial fibrillation, an arrhythmia (or abnormal rhythm) of the upper chambers of the heart. In addition, Cardiome Pharma Corp. has pre-clinical projects that focus on ion channel and cardiovascular research. It also has a collaboration and license agreement with Merck & Co., Inc. for the development and commercialization of BRINAVESS. The company was formerly known as Nortran Pharmaceuticals Inc. and changed its name to Cardiome Pharma Corp. in June 2001. Cardiome Pharma Corp. was founded in 1986 and is headquartered in Vancouver, Canada..

(NYSE:UGAZ) - .

About BUYINS.NET BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include: REGULATORY & COMPLIANCE NEWS Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO INVESTMENTS & TRADING SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER: BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net CONTACT: Buyins.net Thomas Ronk tom@buyins.net www.buyins.net ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.com on the world wide web. Inquiries to info@m2.com.

[ Back To Smart Grid Home's Homepage ]




blog comments powered by Disqus